Why Novo Nordisk Stock Just Popped

Novo Nordisk stock has multiple catalysts that could soon reverse is slide.Novo Nordisk (NVO 5.66%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky 7% through 12:20 p.m. ET Tuesday after London's Financial Times reported local activist hedge fund Parvus Asset Management is building a stake.Reportedly, Parvus is upping its stake to gain more influence in picking a new CEO for Novo. Novo in the newsBuying activity in a stock can help to push a stock price hi ...